Live

Amgen Inc. - Common Stock (AMGN) congressional disclosures

Healthcare · coverage Jan 22, 2024–Sep 5, 2026

Email me the next AMGN filing — free
Tracked disclosures
37
Lawmakers
16
Reported purchase / sale rows
21 / 16A disclosure count, not congressional market sentiment

Estimated market comparison · not an official filing fact

Available with Pro

Average post-trade price move across enriched rows. It is historical, sample-limited, does not account for exact execution prices or portfolio weights, and is not evidence that the filing activity caused a market move.

Disclosure alert preview

Based on a real public filing

Sale

David J. Taylor

AMGNAmgen Inc. - Common Stock

$1K - $15K

Traded
Aug 26, 2026
Filed
Sep 5, 2026
Disclosure delay
10 days
Reported owner
Not normalized

This watch matched after the disclosure became public. It is not a real-time trade signal. Source checked Sep 29, 2026.

Official filing

AMGN congressional trades snapshot

This page summarizes public STOCK Act disclosures involving AMGN. It is useful for seeing which lawmakers reported AMGN transactions, how many filings are visible, the buy/sell mix, and whether the newest public filing describes a recent or delayed trade.

Last updated

Sep 5, 2026

Data source

Public House and Senate STOCK Act disclosures normalized by Congressional Trader.

Key caveat

Filing date can trail transaction date. This page is for research and monitoring, not investment advice.

What the AMGN congressional trade page shows

Congressional Trader tracks 37 public STOCK Act disclosures for AMGNacross 16 lawmakers. This page separates purchases from sales, shows filing delays, and links each disclosure back to the individual politician profile when available.

The most recent AMGN filing shown here was filed on Sep 5, 2026 by David J. Taylor as a sale. Related lawmakers include David J. Taylor, Marjorie Taylor Greene, Jared Moskowitz, Jefferson Shreve, Scott Franklin.

FAQ

Which lawmakers traded AMGN?

Recent AMGN disclosures include David J. Taylor, Marjorie Taylor Greene, Jared Moskowitz, Jefferson Shreve, Scott Franklin.

What is the buy/sell mix for AMGN?

The visible sample currently shows 21 purchases and 16 sales or partial sales.

Should I trade based on AMGN disclosures?

No. This page summarizes public filings for research and monitoring. It is not investment advice.